Skip to main content

Lluis Armadans Gil

Institutions of which they are part

Main researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Lluis Armadans Gil

Institutions of which they are part

Main researcher
Epidemiology and Public Health
Vall Hebron Institut de Recerca

Projects

Ensayo clínico para comparar la inmunogenicidad de una vacuna anti-hepatitis B adyuvada con la de carga antigénica aunmentada en pacientres inmunodeprimidos.

IP: Magda Campins Martí
Collaborators: Manuel Hernández González, Rosa Lopez Martinez , Lluis Armadans Gil, Laia Pinos Tella, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Blanca Borras Bermejo, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil, Lluis Armadans Gil
Funding agency: Instituto de Salud Carlos III
Funding: 73205
Reference: PI18/01887
Duration: 01/01/2019 - 30/06/2023

Factores virológicos y del huésped asociados a una mayor gravedad de la infección por el virus respiratorio sincitial (VRS)

IP: Tomàs Pumarola Suñé
Collaborators: Jose Angel Rodrigo Pendás, Andres Antón Pagarolas, Lluis Armadans Gil, Juliana Esperalba Esquerra
Funding agency: Instituto de Salud Carlos III
Funding: 116765
Reference: PI14/01838
Duration: 01/01/2015 - 30/06/2019

Establecimiento de un modelo para mejorar la comparabilidad de los resultados del Estudiio de Prevalencia de las Infecciones Nosocomiales en España (EPINE)

IP: -
Collaborators: Lluis Armadans Gil
Funding agency: Instituto de Salud Carlos III
Funding: 45375
Reference: PI07/90255
Duration: 01/01/2008 - 31/12/2009

Análisis de la evolución de la prevalencia de las infecciones nosocomiales en España.

IP: -
Collaborators: Lluis Armadans Gil, Magda Campins Martí
Funding agency: Instituto de Salud Carlos III
Funding: 7590
Reference: PI020765
Duration: 06/11/2002 - 06/11/2004

Related news

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

This strategy protects almost two thirds of patients. It also reduces the waiting time between vaccination and initiation of immune suppressive treatment.

El VHIR va participar activament en l'assaig clínic d'aquesta vacuna que avaluava la seguretat, la tolerabilitat i l'eficàcia.

Related professionals

Melissa Panesso Romero

Melissa Panesso Romero

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more
Jorge Garcia Valcarcel

Jorge Garcia Valcarcel

Research assistant
Reconstructive Surgery of the Locomotor System
Read more
Ana Belen Gavilan Saccarello

Ana Belen Gavilan Saccarello

Predoctoral researcher
Infectious Diseases
Read more
Cristina Guirao Martinez

Cristina Guirao Martinez

Research technician
Nephrology and kidney transplantation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.